低分子肝素治疗糖尿病足的近期疗效观察

目的 观察低分子肝素(LWMH)治疗糖尿病足的临床疗效.方法 将54例糖尿病足患者随机分为观察组和对照组.两组均予胰岛素常规降糖,抗感染治疗和常规换药处理.观察组加用LWMH5000IU皮下注射,每12h 1次,共15天.分别观察两组治疗前后血浆内皮素(ET)、血栓素(TXB2)、血液流变学、踝肱指数异常度、溃疡愈合情况及纤维蛋白原(FIB)、凝血酶原时间(PT)、活化部分凝血酶时间(APTT)的变化.结果 观察组在血浆ET、TXB2变化、血液流变学指标的改善和溃疡愈合情况方面优于对照组(P<0.05或P<0.01).两组治疗前后FIB、PT、APTT变化不明显(P>0.05),无出血等并发症.结论 LWMH治疗糖尿病足有效且安全性好.

Obsoervation of Low Molecular Weight Heparin In Treatment of Diabetic Foot

Objective To observe the effect of low molecular weight heparin(LMWH) in treatment of diabetic foot.Methods Fifty-four patients were divided into test group and control group randomly.Both two groups were given routine therapy including mediating blood glucose with Insulin,anti-infection and changing dressings,while the test group were givon LMWH 5000IU once datly every 12 hours for 15 days besides the routine treatment.Then the endothelin(ET),thromboxaneB2(TXB2),hemorheology,ankle-brachial index(ABI),ulcer...